Pfizer-BioNTech to test COVID-19 vaccine booster against South African variant
Researchers at Pfizer-BioNTech announced Thursday that they have started a new clinical trial designed to assess whether a third dose of their COVID-19 will bolster the protection it offers against new virus strains.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
More News: African Health | Clinical Trials | COVID-19 | Health | Pfizer | South Africa Health | Vaccines